Anne Wojcicki, co-founder and former CEO of 23andMe, has bid to buy back the genetic testing platform, which was pronounced ...

San Francisco-based 23andMe filed for Chapter 11 bankruptcy protection in the Eastern Missouri federal court district in ...

The American Diabetes Association’s annual conference kicks off amid a dynamic year for diabetes tech, as access improves for ...

DNA firm is back under old management, Meta is poaching AI talent, TikTok's deadline looms, Kraft goes natural with dyes, and ...

AstraZeneca signed a potential $5 billion research deal with Chinese drugmaker CSPC. Eli Lilly is buying Verve Therapeutics for $1 billion upfront plus a CVR potentially worth another $300 million.